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DEXTRO PROPOXYPHENE AND THE VENTULATORY RESPONSE TO
CARBON DIOXIDE IN MANt
Dextro propoxyphene (Darvon®) is an orally effective analgesic said to be
equipotent on a weight basis with codeine both in experimental animals
and in man.' When administered parenterally in 50 mg. doses it has also
been reported3 to produce analgesia equivalent to that observed following
50 mg. of meperidine. Codeine and meperidine as well as other narcotics
are recognized respiratory depressants when employed in therapeutic
amounts.'" The respiratory depression frequently is not clinically apparent
but is readily detected when technics are employed which allow measure-
ment of the response of the respiratory center to carbon dioxide.' Although
dextro propoxyphene has been reported as producing no grossly evident
alterations in respiration under clinical conditions,"8 its effect on respira-
tion has not been examined under controlled experimental conditions.
The present report concerns the effect of dextro propoxyphene on the
ventilatory response to alterations in carbon dioxide tension experimentally
produced in normal man.
METHODS
Five normal adult male volunteers without history or physical evidence of pulmonary
pathology were studied using technics modified from those described by Eckenhoff, etal.'
immediately prior to and one hour following the oral ingestion of 130 mg. of dextro
propoxyphene (twice the recommended therapeutic oral dose). To assure uniform drug
absorption from the gastro-intestinal tract, all subjects were at least four hours post-
prandial at the time of the study. No subjects had received prior drugs such as aspirin,
caffeine, etc., which might have interfered with the experimental results.
Each subject was studied while respiring through a gas-tight closed-circle circuit
which incorporated an anesthesia face mask, a respirometer, a Beckman-Spinco infra-
red carbon dioxide analyzer, and unidirectional valves so that only expired gases could
reach the detector cell of the carbon dioxide analyzer. Since no provision was made for
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carbon dioxide absorption and since the system was primed with gases containing carbon
dioxide, the concentration of carbon dioxide inhaled was the sum of exogenously
administered carbon dioxide plus endogenously accumulated carbon dioxide. The
analyzer pump of the carbon dioxide analyzer was set to withdraw 500 cc. of expired
gas per minute from the tubing near the subject's mouth. The polyethylene catheter
through which the expired gas was drawn had the same dimensions as the catheter
used to calibrate the analyzer in order to prevent spurious changes in gas pressure
resulting from differences in resistance to flow of gas through the sampling catheter.
The calibration curve of the Beckman-Spinco carbon dioxide analyzer not being linear,
the analyzer was calibrated immediately prior to and following each experimental run.
Calibration was accomplished using known concentrations (as determined by the
micro-Scholander method) of carbon dioxide obtained from individual tanks of 3.15,
5.14, 6.23, 7.11, and 9.21 per cent carbon dioxide in air. The results were recorded on
a Sanborn Twin-Viso recorder set to run at the rate of one centimeter per second. To
minimize drift, the detector cell was turned on at least six hours before beginning an
experiment and was protected from drafts and vibration during the experiment.
Satisfactory sampling of end-tidal air was determined, by the presence of a stable
plateau of carbon dioxide tension in exhaled air. Minute volume was determined using
a Sanborn spirometer with a six-liter reservoir. Since the sample cell pump of the
carbon dioxide analyzer removed 500 cc. of gas from the system per minute, this
volume of gas was added to the reservoir.
Each subject served as his own control. Before dextro propoxyphene was admin-
istered, each subject respired for three minutes from the circuit after it, including the
six-liter reservoir, had been filled with 3.15 per cent carbon dioxide in air. After a suit-
able period during which room air was breathed, this was repeated after the circuit
had been primed with 9.21 per cent carbon dioxide. These two test periods were then
repeated one hour after the drug had been administered. Minute volume was determined
by estimating to the nearest 50 cc. the volume of gas expired during the final 30 seconds
of each breathing period, this figure then being multiplied by two. End-tidal carbon
dioxide tension for the same 30-second period was determined by averaging the carbon
dioxide tension values obtained for each exhalation which occurred during this time.
The per cent carbon dioxide was multiplied by the barometric pressure for that day
minus 47 mm. Hg (correction for water vapor). By plotting minute volume on the
vertical coordinate and carbon dioxide tension on the horizontal coordinate, ventilation-
response curves were obtained for each subject before and after drug administration.
Since only two points were determined on each curve, data on the possible displacement
of the curve by the drug were obtained rather than data on changes in slope of the
curve. This was regarded as acceptable first because the effect of narcotics on the
ventilation-response curve is primarily one of displacement of the curve toward higher
values of pCO2 and only secondarily one of decrease in slope, and second because in the
range of 7 to 10 per cent carbon dioxide the ventilation-response curve can be
considered to be a straight line.7
RESULTS
Results are summarized in the accompanying Figure. Dextro pro-
poxyphene caused no consistent displacement of the ventilation-response
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curves in either direction. In none of the five subjects were the observed
changes physiologically significant. The data also suggest that the drug
caused no significant change in slope of ventilation-response curves;
because only two points were determined on each curve, this cannot be
regarded as conclusive, however.
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FIG. 1. Effect of oral dextro propoxyphene (130 mg.) on ventilation-response curves
in normal man. Horizontal ordinate carbon dioxide tension (mm. Hg). Vertical
ordinate minute volume (liters).
DISCUSSION
The present results indicate that, when administered orally in twice
the recommended therapeutic dose to normal individuals, the analgesic
dextro propoxyphene has no effect on the response threshold of the
respiratory center to carbon dioxide. In this dosage (130 mg.) dextro
propoxyphene can therefore be considered wtihout respiratory depressant
effects. If, as has been suggested, 65 mg. of dextro propoxyphene has
an analgesic effect equal to that produced by 65 mg. of codeine' or by
50 mg. of meperidine,8 then dextro propoxyphene may have a therapeutic
advantage over equianalgesic amounts of codeine and meperidine, both
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of which have demonstrable depressant effects on respiration."5 This
advantage would be especially desirous clinically in patients with pre-
existing inadequacies of pulmonary ventilation. The fact that 130 mg.
of dextro propoxyphene was associated with no subjective changes in
the five patients studied, neither dysphoria nor euphoria being produced,
may also be considered advantageous.
SUMMARY
Dextro propoxyphene (Darvon®) administered orally in twice the
recommended analgesic dose to five normal subjects produced no change
in threshold response of the respiratory center to carbon dioxide. The
analgesic may therefore be considered without respiratory depressant
effects when given in clinically effective amounts.
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